Ophthalmic Devices - Eastern Africa

The Ophthalmic Devices market market in Eastern Africa is anticipated to achieve a revenue of US$108.00m in the year 2024.
It is expected that the revenue will witness a compound annual growth rate (CAGR 2024-2029) of 7.46%, leading to a market volume of US$154.70m by the year 2029.
Comparatively, the United States is projected to generate the highest revenue of US$14.00bn in 2024 among all countries globally.
Eastern Africa is experiencing a growing demand for advanced ophthalmic devices to cater to its increasing population's eye care needs.

Definition:
Ophthalmic devices refer to medical devices used for diagnosis of eye diseases, related surgeries, and vision correction.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Essilor International, Johnson & Johnson, Bausch Health Companies. Further information on the key players can be found in the Market Shares boxes.

Ophthalmology diagnostic & surgical devices
Vision care

Ophthalmology pharmaceuticals
Ophthalmology supplements

The Ophthalmic Devices market in Eastern Africa is experiencing significant growth and development due to several factors. Customer preferences for advanced and innovative ophthalmic devices, along with the increasing prevalence of eye diseases and disorders, are driving the market expansion. Additionally, local special circumstances and underlying macroeconomic factors are contributing to the growth in this region. Customer preferences in Eastern Africa are shifting towards technologically advanced ophthalmic devices. Patients are increasingly seeking high-quality and efficient solutions for their eye-related problems. This has led to a rise in demand for devices such as advanced diagnostic tools, surgical equipment, and contact lenses. The preference for these innovative devices is driven by the desire for accurate diagnosis, effective treatment, and improved visual outcomes. The market is also being driven by the increasing prevalence of eye diseases and disorders in the region. Factors such as aging population, changing lifestyles, and environmental factors contribute to the rising incidence of conditions like cataract, glaucoma, and refractive errors. As a result, there is a growing need for ophthalmic devices to diagnose and treat these conditions. The demand for devices such as intraocular lenses, lasers, and surgical instruments is expected to increase as more people seek treatment for their eye problems. In addition to customer preferences, there are several local special circumstances that are influencing the growth of the Ophthalmic Devices market in Eastern Africa. Limited access to eye care services and a shortage of skilled ophthalmologists in some areas create a need for efficient and cost-effective devices that can be used by non-specialist healthcare providers. This has led to the development and adoption of portable and user-friendly devices that can be used in remote or resource-constrained settings. Furthermore, underlying macroeconomic factors such as increasing healthcare expenditure and improving healthcare infrastructure are contributing to the market growth. Governments in Eastern African countries are investing in healthcare infrastructure development, which includes the establishment of eye care centers and the procurement of advanced ophthalmic devices. This investment is aimed at improving access to eye care services and reducing the burden of eye diseases in the region. In conclusion, the Ophthalmic Devices market in Eastern Africa is witnessing significant growth and development due to customer preferences for advanced devices, the increasing prevalence of eye diseases, local special circumstances, and underlying macroeconomic factors. The demand for technologically advanced devices, driven by the desire for accurate diagnosis and effective treatment, is expected to continue to grow in this region. Additionally, the need for cost-effective and user-friendly devices in resource-constrained settings is driving innovation in the market. With the support of governments and increasing healthcare expenditure, the market is poised for further expansion in the coming years.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.